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Surface mass spectrometry methods can be diﬃcult to use eﬀectively with low cost, portable mass
spectrometers. This is because commercially available portable (single quadrupole) mass spectrometers
lack the mass resolution to conﬁdently diﬀerentiate between analyte and background signals.
Additionally, current surface analysis methods provide no facility for chromatographic separation and
therefore are vulnerable to ion suppression. Here we present a new analytical method where analytes
are extracted from a sample using a solvent ﬂushed across the surface under high pressure, separated
using a chromatography column and then analysed using a portable mass spectrometer. The use of
chromatography reduces ion suppression eﬀects and this, used in combination with in-source
fragmentation, increases selectivity, thereby allowing high sensitivity to be achieved with a portable and
aﬀordable quadrupole mass spectrometer. We demonstrate the eﬃcacy of the method for the
quantitative detection of cocaine and benzoylecgonine in urine and oral ﬂuid. The method gives relative
standard deviations below 15% (with one exception), and R2 values above 0.998. The limits of detection
for these analytes in oral ﬂuid and urine are <30 ng ml1, which are comparable to the cut-oﬀs currently
used in drug testing, making the technique a possible candidate for roadside or clinic-based drug testing.Introduction
Surface mass spectrometry is used in a wide array of disciplines
to obtain chemical information from the surface of a sample.
Since 2004, there has been an increase of techniques that can be
used to liberate molecules from a surface under ambient pres-
sure, followed by mass spectrometry detection. This has resul-
ted in a step-change in sample throughput, due to the fact that
samples no longer need to be analysed under vacuum and
require minimal sample preparation. Surface mass spectrom-
etry techniques include desorption electrospray ionisation
(DESI),1–4 atmospheric pressure matrix assisted laser desorption
ionisation mass spectrometry (AP-MALDI),5–7 plasma assisted
desorption ionisation (PADI),8,9 direct analysis in real time
(DART),10MeV secondary ionmass spectrometry (MeV-SIMS)11,12
and desorption atmospheric pressure chemical ionisation
(DAPCI).13,14 These techniques have shown strength in manyU2 7XH, UK. E-mail: mahado.ismail@
e Hub, Edinburgh Way, Harlow, Essex
dation Trust, Guildford Road, Chertsey,
tion (ESI) available. See DOI:
Chemistry 2016areas, but the absence of a chromatography step leaves the
methods vulnerable to ion suppression eﬀects.
In parallel to the development of ambient ionisation
methods, a range of mass spectrometers have been mini-
aturised and tested for portable mass spectrometry.15–21 Various
combinations of these have been used in conjunction with
methods such as DESI and paper spray to support portable
analysis of drugs.15,18,22 However, the limitation of miniaturised
or portable mass spectrometers is that they are less powerful
than lab based instruments in terms of resolving power and
sensitivity.23 This is problematic when encountering complex
mixtures of samples. This combined with the issue of ion
suppression eﬀects, limits the selectivity, sensitivity and quan-
titative power of the portable mass spectrometry approaches to
surface analysis.
In this work, we present a method that attempts to overcome
the limitations of surface analysis by introducing a chromatog-
raphy step. In the method, a solvent is ushed across the
sample surface under pressure to extract analytes and the
resulting solution is passed through a chromatography column
before analysis using a portable mass spectrometer. The result
is a low cost, sensitive and selective method of surface analysis.
Recent developments in a related technique, liquid extrac-
tion surface analysis (LESA)24–30 have demonstrated the capa-
bility of using a liquid microjunction to extract analytes from
a sample surface. The extracted analytes are collected inAnal. Methods
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View Article Onlinea pipette tip and are sprayed into a mass spectrometer using
a nano-electrospray source. However, LESA has limited porta-
bility as it requires a separate instrument to facilitate the
chromatography step.31
Recent work by Oliveira et al.32 has shown that therapeutic
drugs in dried blood spots can be extracted from a surface,
passed through a chromatography column and analysed using
high resolution mass spectrometry. In this work, we test for the
rst time the feasibility of using a similar method to Oliveira et al.
of surface extraction and chromatography, but using a portable
mass spectrometer and in-source fragmentation for portable
diagnostics. Our method can be broadly applied to the detection
and quantication of compounds on at surfaces without sample
preparation. We show how the method could be applied as
a portable and rapid diagnostic test for cocaine and its primary
metabolite (benzoylecgonine) in urine and oral uid, with
potential applicability to roadside or workplace drug testing.Experimental methods
Reagents and materials
Solvents (LC-MS grade) used for analysis were all purchased from
Fisher Scientic (Loughborough, UK). Formic acid (99%) used for
the mobile phase was purchased from Fisher Scientic (Lough-
borough, UK). The certied reference materials (CRM) for
cocaine and benzoylecgonine (at 1 mg ml1 in solution) and
cocaine-d3 (100 mg ml
1 in solution used as internal standard)
were purchased from Sigma Aldrich (Dorset, UK). All drugs and
deuterated internal standards were stored at 20 C. Whatman
grade 1-chromatography paper was purchased from VWR
(Leicestershire, UK) and used as a sample substrate. Sterilin™
polystyrene containers used for collection of urine was purchased
from Scientic Laboratory Supplies (Nottingham, UK).Sample collection
Negative control oral uid samples were collected from healthy
(drug-free) volunteers (n ¼ 10, 5 male and 5 female) in the
laboratory at the University of Surrey using a syringe. The oral
uid samples, 1 ml per volunteer, were pooled and used to
prepare blank and spiked solutions of cocaine and benzoy-
lecgonine. In addition, urine samples were collected in carcin-
ogen containers (Scientic Laboratory Supplies, Nottingham,
United Kingdom) from healthy (drug-free) volunteers (n ¼ 3
males). The urine samples were pooled. An aliquot of pooled
urine was reserved as negative control, and the remainder was
spiked with cocaine and benzoylecgonine.
Urine and oral uid samples were also collected from two
individuals seeking treatment for drug dependency at a drug
and alcohol service, to show the applicability of the method to
real samples. Urine samples were collected in Sterilin™ poly-
styrene containers and corresponding oral uid samples were
collected using Quantisal™ collection devices (Alere Toxi-
cology, United Kingdom). Samples were stored at 4 C and
analysed 4 weeks aer sample collection. A favourable ethical
opinion was granted from the National Research Ethics Service
(NRES) for the collection and analysis of these samples (IRASAnal. MethodsID: 142223 and study ID: 17487). Informed consent was ob-
tained from all subjects prior to sample collection.
Sample preparation
Oral uid. A stock solution (1 mg ml1) of cocaine and ben-
zoylecgonine was prepared in water by dilution of the CRM on
the day of analysis. The pooled oral uid samples were used to
prepare calibration standards over the range 0–600 ng ml1 in
pooled oral uid by dilution of the stock solution. Internal
standards were prepared by dilution of the CRM in water and
spiked into the calibration standards to produce a nal
concentration of 150 ng ml1. Commercially available oral uid
collection devices (Quantisal collection device, Alere Toxicology,
United Kingdom) were used to absorb the calibration standards
prepared in pooled oral uid. This sampling method was
applied to simulate drug testing using oral uid devices. When
1ml (10%) of oral uid was collected in the collection pad, the
indicator on the stick turned blue and was placed in the
collection tube containing a buﬀer (3 ml). For the samples
collected from individuals at the drug treatment service,
internal standard solution was spiked into the buﬀer of the
Quantisal device to produce a nal concentration of
150 ng ml1.
Urine. Urine was collected in carcinogen pots and stored at
4 C until required for sample preparation. Samples were
prepared on the day of analysis. Urine samples were pooled and
subsequently used to prepare a stock solution of cocaine and
benzoylecgonine in pooled urine at 1 mg ml1 by dilution of the
CRM. Calibration standards over the range 0–600 ng ml1 were
prepared in pooled urine by serial dilution of the stock solution.
Internal standards were prepared at 1 mg ml1 in pooled (drug-
free) urine and spiked into the calibration standards to produce
a nal concentration of 100 ng ml1.
Instrumentation
Plate Express™ with expression compact mass spectrometer
(Advion Inc. Ithaca, USA). The Plate Express is designed for
sample extraction from a variety of at surfaces (such as glass,
paper, aluminium foil and TLC plates). The system is equipped
with an oval shaped elution head (4  2 mm, with a depth of
250 mm), a laser targeting device, and automated head cleaning
with high pressure gas. The sample is placed under the elution
head and themotor drives the head down to touch the sampling
plate, then drives further down to compress the spring and
generate the force required to seal the spot for extraction. The
head has an oval shaped knife edge that is used to seal against
the surface material. Inside the knife edge there is a frit that
lters the eluted sample before being introduced onto the
column for separation and subsequent mass spectral analysis.
Fig. 1 shows the Plate Express™ connected to a binary pump
used to generate a gradient (see Table 1) for chromatographic
separation. Chromatographic separation was carried out using
an Ultra BiPh column (50 mm 2.1 mm, 5 mm) purchased from
Restek (Pennsylvania, USA) for the separation of cocaine and
benzoylecgonine. Chromatographic separation was previously
optimised for cocaine and relatedmetabolites (benzoylecgonineThis journal is © The Royal Society of Chemistry 2016
Fig. 1 Schematic of the Plate Express combined with expression compact mass spectrometer. The compact expression mass spectrometer is
single quadrupole mass analyser with a mass range 10 to 2000 amu. The detector is a dynode combined with an electron multiplier scanning
every 2 ms. The mass spectrometer weighs 32 kg, dimensions 66  28  56 cm (length  width  height) and a power consumption of 300 VA
maximum. The instrument is equipped with a rotary pump weighing 30 kg with dimensions 26 23 46 cm. Themass resolution is comparable
to other portable mass spectrometers, at 0.5–0.7m/z (full width half maximum) atm/z 1000 units sec1. The sensitivity is 10 pg reserpine in SIM
mode.
Table 1 Binary gradient method for separation of cocaine and ben-
zoylecgonine using an Ultra BiPh column (50 mm  2.1 mm, 5 mm)
with solvent A: 0.1% formic acid in water and solvent B: 0.1% formic
acid in acetonitrile
Flow (ml min1) A (%) B (%) Time (min) Gradient type
0.1 95 5 0.1 Step
0.1 95 5 2.0 Step
0.5 95 5 1.0 Linear
0.5 80 20 2.0 Linear
0.5 0 100 1.0 Step
0.5 95 5 1.0 Step
Paper Analytical Methods
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View Article Onlineand ecgonine methyl esters) on a Waters 2695 separation
module and Micromass Quattro Ultima mass spectrometer
(see Supplemental Material† for an example chromatogram).
This method was adopted for the analysis of cocaine and
benzoylecgonine on the Plate Express system using the same
optimised gradient with lower ow rate. An electrospray ion-
isation (ESI) source was used in positive ion mode for ionisa-
tion. Ion source and mass spectrometer settings were as
followed: capillary temperature, 250 C; capillary voltage,
150 V; source voltage, 25 V; source voltage dynamic, 30 V; gas
temperature, 200 C; ESI voltage, 3.5 kV. The source voltage
and source voltage dynamic were optimised to produce mild
in-source fragmentation of the analytes of interest. Analysis
was performed in selected ion monitoring (SIM) mode for
cocaine (m/z 304 > m/z 182), benzoylecgonine (m/z 290 > m/z
168), cocaine-d3 (m/z 307 > m/z 185) and benzoylecgonine-d3
(m/z 293 > m/z 171).
Analysis of cocaine and benzoylecgonine in urine and oral
uid. 10 ml of sample was added to the paper (WhatmanThis journal is © The Royal Society of Chemistry 2016chromatography paper, grade 1 Chr) and analysed immedi-
ately. Replicate measurements (n ¼ 3) were carried out by
adding 10 ml of the sample onto three separate sample
substrates taped to a microscopic glass slide. A continuous
solvent ow was used to extract the analytes from the sample
substrate. The analytes were extracted and separated using
a binary gradient of 0.1% formic acid in water and 0.1% formic
acid in acetonitrile, as shown in Table 1. The initial ow rate
was set to 0.1 ml min1 to move the extracted sample past the
valve without causing too much back-pressure, as this would
cause the seal to leak. Extraction of the analytes from the
sample surface is achieved by the initial composition of the
binary gradient.Results and discussion
Analytical performance – urine samples
Chromatographic separation of cocaine and benzoylecgo-
nine in spiked urine samples. Extracted ion chromatograms
(XIC) of blank and spiked (200 ng ml1 cocaine and benzoy-
lecgonine) pooled urine are shown in Fig. 2A and B, respec-
tively. The run time for each sample was 7 min and
the respective retention times for cocaine and benzoylecgo-
nine were 4.13 min and 4.01 min. Conrmation of the pres-
ence of cocaine and benzoylecgonine was achieved by
in-source fragmentation. XICs for the fragment ions corre-
sponding to cocaine (m/z 182) and benzoylecgonine (m/z 168)
are also shown in Fig. 2 (with the same retention times as
the respective molecular ions). The XIC of blank (drug-
free) urine (see Fig. 2A) showed no interferences
from endogenous analytes for the fragment ions of both
analytes.Anal. Methods
Fig. 2 Extracted ion chromatograms (XIC) for (A) cocaine and (B) benzoylecgonine in blank urine. XICs for (C) cocaine and (D) benzoylecgonine
in spiked (200 ng ml1 cocaine and benzoylecgonine) urine standard.
Fig. 3 Calibration curve for cocaine (m/z 182) and benzoylecgonine (m/z 168) in pooled urine analysed using Plate Express™ coupled with an
expression compact mass spectrometer (CMS) with cocaine-d3 (m/z 185) internal standard.
Anal. Methods This journal is © The Royal Society of Chemistry 2016
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View Article OnlineCalibration curves. Calibration curves for cocaine and ben-
zoylecgonine in pooled urine were linear over the range 0–600
ng ml1 (Fig. 3). Calibration curves were plotted as concentra-
tion, against the ratio of the analyte peak area (blank corrected)
to internal standard (IS) cocaine-d3 peak area, and had R
2 values
of at least 0.998 for urine. The precision was evaluated by
calculating the relative standard deviations (RSD) % of replicate
measurements (n¼ 3) of the calibration standards (see Table 2).
The use of deuterated labelled internal standards provided RSD
values below 15% for cocaine and benzoylecgonine. The only
exception was benzoylecgonine (at 50 ng ml1) in pooled urine,
which produced an RSD value of 23%.Table 2 Analytical performance characteristics for cocaine and ben-
zoylecgonine in urine
Analyte Slope R2
Linear range
(ng ml1) RSD (%)
Cocaine 0.01217 0.9998 0–600 <12
Benzoylecgonine 0.00632 0.9987 0–600 <23
Fig. 4 Extracted ion chromatograms (XIC) for (A) cocaine and (B) benz
lecgonine in spiked (200 ng ml1 cocaine and benzoylecgonine) oral ﬂu
This journal is © The Royal Society of Chemistry 2016Analytical performance – oral uid samples
Extracted ion chromatograms (XIC) of blank and spiked (200
ng ml1 cocaine and benzoylecgonine) pooled oral uid are
shown in Fig. 4A and B, respectively. The respective retention
times for cocaine and benzoylecgonine were 4.12 min and
4.01 min. XICs for the fragment ions corresponding to cocaine
(m/z 182.1) and benzoylecgonine (m/z 168.1) are also shown in
Fig. 4 (with the same retention times as the respective molecular
ions). The chromatograms of blank (drug-free) oral uid (see
Fig. 4A) showed no interferences from endogenous analytes for
both analytes.
Calibration curves. Calibration curves for pooled oral uid
spiked with cocaine and benzoylecgonine were linear over the
range 0–600 ng ml1 with R2 values of at least 0.998 (Fig. 5). The
RSD for cocaine and benzoylecgonine in oral uid was below
11% as shown in Table 3.
Method sensitivity. The sensitivity of the method was
determined by calculating the limit of detection (LOD) and limit
of quantitation (LOQ) for cocaine and benzoylecgonine using
LOD ¼ yblank + 3sblank and LOQ ¼ yblank + 10sblank. Where, yblank
is the mean blank signal and sblank is the standard deviation ofoylecgonine in blank oral ﬂuid. XICs for (C) cocaine and (D) benzoy-
id standard.
Anal. Methods
Fig. 5 Calibration curve for cocaine (m/z 304) and benzoylecgonine (m/z 290) in pooled oral ﬂuid analysed using Plate Express™ with an
expression compact mass spectrometer (CMS) with cocaine-d3 (m/z 185) internal standard.
Analytical Methods Paper
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View Article Onlinethe blank signals. Calculated LODs are given in Table 4 for urine
and oral uid, respectively.
Cut-oﬀ levels currently employed for drug testing based on
urinalysis are 150 ng ml1 for initial screening and 150 ng ml1
for conrmation tests for cocaine.33 Similar work by Kirby et al.
investigated the use of a portable mass spectrometer combined
with digital microuidics for the quantitation of cocaine in
dried urine and achieved LOQ of 40 ng ml1 for cocaine.34 The
LOQs presented in Table 4 demonstrate the applicability of this
new analytical method for cocaine detection in the context of
these cut-oﬀ guidelines with better sensitivity.
Cut-oﬀ levels used by UK forensic providers for oral uid
screening and conrmatory tests are 30 ng ml1 and 8 ng ml1
for cocaine, respectively.33 The LOQs for oral uid for cocaine
and benzoylecgonine shown in Table 4 are slightly above the
cut-oﬀ levels currently employed. A limitation in this prelimi-
nary study was that only one oral uid collection device
(Quantisal™ collection kits) was tested. Furthermore, the oralTable 3 Analytical performance characteristics for cocaine and ben-
zoylecgonine in oral ﬂuid
Analyte Slope R2
Linear range
(ng ml1) RSD (%)
Cocaine 0.02396 0.9981 0–600 <5
Benzoylecgonine 0.00893 0.9981 0–600 <11
Table 4 Limit of detection (LOD) and quantitation (LOQ) for cocaine
and benzoylecgonine in pooled urine and pooled oral ﬂuid
Sample Analyte LOD (ng ml1) LOQ (ng ml1)
Pooled urine Cocaine 10 19
Benzoylecgonine 21 42
Pooled oral uid Cocaine 31 44
Benzoylecgonine 17 27
Anal. Methodsuid samples were diluted using the oral uid collection device
as the collection pad is stored in 3 ml of extraction buﬀer and
a further 0.5 ml of internal standard was added to the buﬀer.
Only 10 ml of the resulting buﬀer solution was used for analysis.
Therefore, the sensitivity was limited by the sampling collection
method and could be improved by collecting oral uid samples
in a smaller volume of buﬀer. Future work will also explore the
extraction eﬃciency from the surface, use of diﬀerent extraction
solvents or alternative substrates to improve the sensitivity. It
should be noted that in the conguration described in this
paper, the initial mobile phase composition is used as the
extraction solvent.Cocaine and benzoylecgonine in samples from patients
Oral uid. Analysis of oral uid samples collected from two
patients attending an NHS drug & alcohol service showed
detectable signals for cocaine and benzoylecgonine. Fig. 6
shows extracted ion chromatograms obtained from the analyses
of pooled oral uid samples using the new analytical method
described previously. Fig. 6A and B show an extracted ion
chromatogram of blank (pooled) oral uid sample which indi-
cates that no peak was obtained for cocaine and benzoylecgo-
nine. Analysis of oral uid samples from patients shows that
peaks corresponding to cocaine (4.13 min) and benzoylecgo-
nine (4.01 min) are detected with their corresponding fragment
ions (seen in Fig. 6C and D).
Urine. In addition to the oral uid samples, corresponding
urine samples were collected from these patients. Analysis of
the urine samples showed that benzoylecgonine was present.
No peaks were observed for the parent drug (cocaine). This is to
be expected because cocaine is metabolised through the body
before being excreted and so metabolite concentrations are
higher in urine than in oral uid.35 Another possibility for the
absence of cocaine is the fact that the samples were not stabi-
lised and therefore the cocaine may have been converted to
benzoylecgonine.36This journal is © The Royal Society of Chemistry 2016
Fig. 6 Extracted ion chromatograms (XIC) for (A) cocaine and (B) benzoylecgonine in blank oral ﬂuid. XICs for (C) cocaine and (D) benzoy-
lecgonine in an oral ﬂuid sample obtained from a patient attending an NHS drug & alcohol service.
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View Article OnlineOral uid is used by law enforcement agencies for road
side drug testing. Current devices based on antibody assays
lack specicity and quantitative power. This work demon-
strates the proof of concept, and that a portable mass spec-
trometry system for these campaigns should be investigated
further. Additionally, urine analysis is used in a wide array
of clinical applications and a low cost system for
urine screening opens up possibilities of citing such an
instrument in accident and emergency departments or GP
practices.
The set up described here costs approximately £45k to
install, with the mass spectrometer accounting for the
majority of this cost. This can be compared with lab-based
equipment used in toxicology that is typically an order of
magnitude more expensive. This set up described here could
potentially be interfaced with other portable mass spectrom-
eters and indeed other congurations with increased porta-
bility could be investigated in the future. The system described
here has the limitation of coming together with a 30 kg
roughing pump, but has been used previously from the back of
a van37 and therefore road side testing either with the mass
spectrometer used here or a lighter alternative, is a real
possibility for the future.This journal is © The Royal Society of Chemistry 2016Conclusions
The method presented here oﬀers a low cost, exible and
portable set up for analysis of analytes on at surfaces. Whilst we
have demonstrated the proof of concept for mobile drug testing
of oral uid and urine, there is a wide range of potential appli-
cations for which this methodology could be used. We have
developed a new way to screen and quantify cocaine and related
metabolite (benzoylecgonine) in biological uids, using
a combination of surface extraction, liquid chromatography and
portable mass spectrometry. We have demonstrated the proof of
concept for testing for cocaine in urine and oral uid from
patients. We have shown relevant levels of sensitivity
(<30 ng ml1) in these matrices, good linearity (R2 0.998) and
relative standard deviations below 23% for replicate measure-
ments. We therefore conclude that this conguration could be
a candidate for roadside drug testing investigations in the future.Acknowledgements
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